In the largest study yet to assess the long-term safety and efficacy of the adjustable transobturator male system (ATOMS) to treat incontinence in men following invasive prostate treatment, the ...
UroMems, a company developing technology to treat stress urinary incontinence (SUI), received investigational device exemption (IDE) approval from FDA and French National Agency for the Safety of ...
On Wednesday, Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC has begun manufacturing the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male ...
Boston Scientific has launched a docuseries campaign to remove the stigma of male incontinence. Across the videos, the campaign tells the stories of how incontinence upended the lives of three men—and ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
LAS VEGAS -- After decades of use, the artificial urinary sphincter (AUS) finally has high-level evidence of its safety and efficacy for stress urinary incontinence (SUI) in men. What's more, patients ...
FREEHOLD, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision ...
NEW YORK (Reuters Health) - It's not just women who suffer from urinary incontinence: Nearly one in twenty U.S. men have moderate to severe forms of the condition, which is as common as one in six ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results